Apellis Pharmaceuticals shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by T. Rowe Price Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 49k | 22.64 |
| 2025-06-30 | $854k | 49k | 17.32 |
| 2024-12-31 | $1.5M | 48k | 31.92 |
| 2024-09-30 | $86M | 3.0M | 28.84 |
| 2024-06-30 | $155M | 4.0M | 38.36 |
| 2024-03-31 | $271M | 4.6M | 58.78 |
| 2023-09-30 | $248M | 6.5M | 38.04 |
| 2023-06-30 | $514M | 5.6M | 91.10 |
| 2023-03-31 | $380M | 5.8M | 65.96 |
| 2022-12-31 | $302M | 5.8M | 51.71 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management